E
Oaktree Acquisition Corp. III Life Sciences OACC
$10.44 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 09/30/2024
Total Cash And Short-Term Investments 8.11% --
Total Receivables -- --
Inventory -- --
Prepaid Expenses -12.54% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 5.30% --

Total Current Assets 5.30% --
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 0.95% 558.76%
Total Assets 0.98% 558.76%

Total Accounts Payable -3.56% --
Total Accrued Expenses -- -60.34%
Short-term Debt 0.00% --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities 11.51% 657.92%
Total Other Current Liabilities 11.51% 657.92%
Total Current Liabilities 5.73% 640.60%

Total Current Liabilities 5.73% 640.60%
Long-Term Debt -- --
Short-term Debt 0.00% --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 0.93% --
Total Liabilities 0.96% 640.60%

Common Stock & APIC 0.00% 0.00%
Retained Earnings -0.30% -176.44%
Treasury Stock & Other -- --
Total Common Equity -0.30% -403.95%

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity -0.30% -403.95%
Total Preferred Equity -- --
Total Minority Interest -- --
Total Equity -0.30% -403.95%